AccessibilityHelp

Most Active Stocks Daily Stock Gainers Daily Stock Losers

Most Active Stocks Daily Stock Gainers Daily Stock Losers

Todd Campbell

XMFEBCapital

Todd has been helping buy side portfolio managers as an independent researcher for over a decade. In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn.

Articles by Todd Campbell — Page 86

How DexCom Can Fight Back Against Medtronic's Artificial Pancreas

Oct 6, 2016 by Todd Campbell

How DexCom Can Fight Back Against Medtronic's Artificial Pancreas

The approval of Medtronic's Minimed 670G could reshape the type 1 treatment market next year, but I wouldn't count DexCom out. Its best-in-class technology could position it to capture a significant share of the artificial pancreas market in the future.

GettyImages-507404698

Oct 5, 2016 by Todd Campbell, Dan Caplinger, Neha Chamaria, Matt DiLallo, Steve Symington, and Jamal Carnette, CFA

7 Top Stocks to Buy in October

Our Motley Fool contributors think it's smart to add these gems to your portfolio before the flood of third-quarter earnings reports.

market crash image getty 2

Oct 4, 2016 by Todd Campbell

Why Dynavax Technologies Fell 13% Today

Worries are mounting that the FDA will issue a regulatory red light soon for the company's lead drug candidate.

Why Trinity Biotech Is Crashing 51% Today

Oct 4, 2016 by Todd Campbell

Why Trinity Biotech Is Crashing 51% Today

The surprising withdrawal of an application for approval at the FDA is sending shares reeling.

How You Can Save Money on Healthcare

Oct 3, 2016 by Todd Campbell and Kristine Harjes

How You Can Save Money on Healthcare

These money-saving tips can take some of the sting out of skyrocketing healthcare costs.

GettyImages-137086238

Oct 1, 2016 by Todd Campbell

Tax Tips for Americans in Their 50s

How people in their 50s can keep more of their money for retirement by paying less in income taxes.

retirees on computers GettyImages-200470267-001

Oct 1, 2016 by Todd Campbell

Money-Saving Healthcare Tips For Retirees

Medicare only goes so far. if you're trying to free up money in your monthly budget, consider these healthcare cost-savings tips.

PTCT2

Sep 30, 2016 by Todd Campbell

Why PTC Therapeutics Stock Soared 21% Today

Collaboration partner Roche Holdings is enrolling patients in a study of RG7916, a therapy for spinal muscular atrophy.

woman thinking computer GettyImages-505825206

Sep 30, 2016 by Todd Campbell, Selena Maranjian, and Dan Caplinger

When It's OK (and Not OK) to Get Into Debt

Debt can put you on the fast track to financial insecurity, but there are times when debt can be necessary and helpful.

Aerie Pharmaceuticals Could Still Be a Bargain After Its Run-Up

Sep 29, 2016 by Todd Campbell

Aerie Pharmaceuticals Could Still Be a Bargain After Its Run-Up

Aerie Pharmaceuticals' potential to revolutionize glaucoma treatment could lead to blockbuster sales one day.

One Biotech Crashes, the Other Skyrockets -- Here's Why

Sep 29, 2016 by Todd Campbell and Kristine Harjes

One Biotech Crashes, the Other Skyrockets -- Here's Why

Hit-or-miss data, delays, and contentious debate preceded the FDA's green-lighting of the first drug to target the cause of Duchenne muscular dystrophy. Meanwhile, a disappointing data readout stops one vaccine maker in its tracks.

3 Reasons to Buy Array Biopharma

Sep 27, 2016 by Todd Campbell

3 Reasons to Buy Array Biopharma

Upcoming catalysts including a FDA decision on its melanoma medicine could help shares move higher.

man in front of mic GettyImages-112156291

Sep 27, 2016 by Todd Campbell

Opko Health Has Big News on Deck

Results from a late stage trial of Opko Health Inc.'s long-lasting human growth hormone are expected later this year.

kite image top

Sep 27, 2016 by Todd Campbell

How Kite Pharma Could Change Cancer Treatment Forever

Results from a registration-ready study of its promising CAR-T therapy KTE-C19 suggest a new and effective way to tackle hematological cancers is imminent.

pharma pill on money stockmonkeys com

Sep 27, 2016 by Todd Campbell

Here's Why Juno Therapeutics Is Shooting 10% Higher Today

Positive trial results from Kite Pharma are rekindling interest in Juno Therapeutics' CAR-T research program.

This Marijuana Stock Is on a Roll

Sep 26, 2016 by Todd Campbell

This Marijuana Stock Is on a Roll

GW Pharmaceuticals' Epidiolex outpaces placebo in a second trial in Lennox-Gastaut syndrome patients.

millennials GettyImages-518729558

Sep 25, 2016 by Todd Campbell

Personal-Finance Tips for Millennials

Making these smart money moves when you're young could go a long way toward achieving financial freedom.

How to Make the Most of Medicare

Sep 25, 2016 by Todd Campbell and Kristine Harjes

How to Make the Most of Medicare

Unraveling the ins and outs of Medicare, including what it covers, what it costs, and what stocks move higher or lower because of it.

Tax Tips GettyImages-514276702

Sep 24, 2016 by Todd Campbell

Tax Moves You Should Make Right Now

There's still time to take advantage of these tax-lowering strategies in 2016.

pills on gold GettyImages-519336818

Sep 24, 2016 by Todd Campbell

3 Biotechs That Could Be M&A Targets

These three cancer drug stocks could have the best shot at getting acquired.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services